CXCL8 and thyroid cancer: This different ability of metformin to inhibit the secretion of CXCL8 suggested that in normal thyrocytes and thyroid cancer cell lines bear different secretory pathways of CXCL8 which would imply that specific inhibitory strategies are required [12, 27].